GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Simulations Plus Inc (NAS:SLP) » Definitions » Enterprise Value

SLP (Simulations Plus) Enterprise Value : $601.43 Mil (As of Dec. 15, 2024)


View and export this data going back to 1997. Start your Free Trial

What is Simulations Plus Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Simulations Plus's Enterprise Value is $601.43 Mil. Simulations Plus's EBIT for the trailing twelve months (TTM) ended in Aug. 2024 was $6.13 Mil. Therefore, Simulations Plus's EV-to-EBIT ratio for today is 98.10.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Simulations Plus's Enterprise Value is $601.43 Mil. Simulations Plus's EBITDA for the trailing twelve months (TTM) ended in Aug. 2024 was $11.80 Mil. Therefore, Simulations Plus's EV-to-EBITDA ratio for today is 50.99.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Simulations Plus's Enterprise Value is $601.43 Mil. Simulations Plus's Revenue for the trailing twelve months (TTM) ended in Aug. 2024 was $70.01 Mil. Therefore, Simulations Plus's EV-to-Revenue ratio for today is 8.59.


Simulations Plus Enterprise Value Historical Data

The historical data trend for Simulations Plus's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Simulations Plus Enterprise Value Chart

Simulations Plus Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,071.95 769.94 1,089.79 772.78 707.60

Simulations Plus Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 772.78 669.85 721.85 847.12 707.60

Competitive Comparison of Simulations Plus's Enterprise Value

For the Health Information Services subindustry, Simulations Plus's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Simulations Plus's Enterprise Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Simulations Plus's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Simulations Plus's Enterprise Value falls into.



Simulations Plus Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Simulations Plus's Enterprise Value for the fiscal year that ended in Aug. 2024 is calculated as

Simulations Plus's Enterprise Value for the quarter that ended in Aug. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Simulations Plus  (NAS:SLP) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Simulations Plus's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=601.429/6.131
=98.10

Simulations Plus's current Enterprise Value is $601.43 Mil.
Simulations Plus's EBIT for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.13 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Simulations Plus's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=601.429/11.796
=50.99

Simulations Plus's current Enterprise Value is $601.43 Mil.
Simulations Plus's EBITDA for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $11.80 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Simulations Plus's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=601.429/70.013
=8.59

Simulations Plus's current Enterprise Value is $601.43 Mil.
Simulations Plus's Revenue for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $70.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Simulations Plus Enterprise Value Related Terms

Thank you for viewing the detailed overview of Simulations Plus's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Simulations Plus Business Description

Traded in Other Exchanges
N/A
Address
42505 Tenth Street West, Lancaster, CA, USA, 93534-7059
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
Executives
Walter S Woltosz director, 10 percent owner, officer: Chairman and CEO 42505 10TH ST. WEST, LANCASTER CA 93534
Lisa Lavange director 42505 10TH ST., WEST, LANCASTER CA 93534
Daniel L Weiner director 800 WEST EL CAMINO REAL, SUITE 200, MOUNTAIN VIEW CA 94040
John Kenneth Paglia director 746 GRABLE PLACE, NEWBURY PARK CA 91320
Dibella John Anthony Ii officer: Division President 42505 10TH STREET WEST, LANCASTER CA 93534
Steven Chang officer: President, Immunetrics 42505 10TH STREET WEST, LANCASTER CA 15203
Shawn Oconnor officer: Chief Executive Officer 42505 10TH STREET WEST, LANCASTER CA 93534-7059
Jill Fiedler-kelly officer: President, Cognigen Division 42505 10TH STREET WEST, LANCASTER CA 93534
Brett Howell officer: President, DILIsym Division 42505 10TH STREET WEST, LANCASTER CA 93534
William W Frederick officer: CFO C/O SIMULATIONS PLUS, INC., 42505 10TH STREET WEST, LANCASTER CA 93534
Sharlene Evans director 42505 10TH STREET WEST, LANCASTER CA 93534
Nguyen Nguyen officer: VP of Human Resources 42505 TENTH STREET WEST, LANCASTER CA 93534
David L. Ralph director 42505 10TH STREET WEST, LANCASTER CA 93534
John Robert Kneisel officer: CFO 42505 10TH STREET WEST, LANCASTER CA 93534
Grasela Thaddeus Henry Jr director, officer: President 1780 WEHRLE DRIVE SUITE 110, BUFFALO NY 14221